세계의 안내 렌즈(IOL) 임플란트 시장 보고서(2025년)
Intraocular Lens (IOL) Implants Global Market Report 2025
상품코드 : 1810927
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,493,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,386,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,279,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

안내 렌즈(IOL) 임플란트 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 6.6%로 성장할 전망이며, 65억 1,000만 달러로 성장이 예측됩니다. 예측 기간에 성장의 원동력은 고급 안내 렌즈(IOL) 수요 증가, 외래 백내장 수술 증가, 펨토 세컨드 레이저 지원 수술의 보급, 시력 케어에 대한 정부의 지원책, 신흥 시장에서의 안과 의료에 대한 액세스 개선 등이 전망됩니다. 예상되는 주요 동향으로는 토릭 안내 렌즈 및 다 초점 안내 렌즈로의 전환, 수술 방법의 지속적인 발전, 안과에서 인공지능의 통합, 광 조절 가능한 렌즈 개발, 개별화된 시력 교정 솔루션에 대한 선호도가 높아집니다.

백내장 수술 건수 증가가 안내 렌즈(IOL) 임플란트 시장의 성장을 견인할 것으로 예측됩니다. 백내장 수술은 눈이 흐린 천연 렌즈를 제거하고 인공 안내 렌즈로 교체하여 선명한 시야를 되찾는 것입니다. 백내장 수술 증가는 주로 노화로 인한 것으로, 백내장은 외과적 치료를 필요로 하는 시력 장애를 일으키기 쉬운 노인들에게 많이 나타납니다. 안내 렌즈 임플란트는 투명한 인공수정체로 탁한 수정체를 대체하여 백내장 수술 결과를 개선하여 보다 선명한 시력, 안경 의존성 감소, 신속한 회복, 장기적인 시력 안정성을 제공합니다. 예를 들어, 미국의 안과 전문지 'EyeWorld Magazine'의 보고서에 따르면, 2022년에는 미국에서 약 9,750명의 백내장 외과의사가 460만 건의 수술을 실시해, 1명 평균 472건의 수술을 실시했습니다. 2030년까지 약 10,000명의 외과의사가 연간 600건에 가까운 수술을 할 것으로 예측됩니다. 이 동향은 백내장 수술 건수 증가에 견인되는 안내 렌즈 임플란트 수요 증가를 부각하고 있습니다.

안내 렌즈 임플란트 시장의 주요 기업은 시력 결과를 개선하고 환자의 안경에 대한 의존도를 줄이기 위해 차세대 노안 교정 렌즈의 개발에 주력하고 있습니다. 이러한 첨단 렌즈는 노안 환자의 다양한 거리(근방, 중간, 먼)에서 선명한 시력을 회복하도록 설계되었습니다. 백내장 수술 후 노안경과 원근 양용 안경의 필요성을 최소화하거나 제거하여 시각적 자립을 높이고 삶의 질을 향상시킵니다. 예를 들어 미국 제약회사 존슨 엔드 존슨은 2025년 6월 모든 거리와 조명 조건 하에서 선명한 시야를 제공하는 차세대 안내 렌즈 '테크니스 오디세이'를 발표했습니다. 이 렌즈는 첨단 광학계와 독자적인 회절면을 결합하여 후광이나 눈부심과 같은 야간 시각 장애를 줄이면서 지속적이고 고대비의 시야를 제공합니다. 이 혁신은 백내장 환자에게 시각의 자유와 삶의 질을 향상시키는 것을 목표로 합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Intraocular lens (IOL) implants are artificial lenses surgically placed inside the eye to replace the natural lens, most commonly removed during cataract surgery. These implants help restore clear vision by focusing light directly onto the retina after the cloudy natural lens is extracted.

The primary types of intraocular lens implants include non-foldable and foldable lenses. Non-foldable lenses, typically made from polymethyl methacrylate (PMMA), are rigid and require larger incisions during surgery due to their inability to fold. IOLs are manufactured from a range of materials such as silicone, PMMA, hydrophilic acrylic, hydrophobic acrylic, and hybrid materials. These implants are used across various surgical techniques, including phacoemulsification, extracapsular cataract extraction (ECCE), small incision cataract surgery (SICS), and femtosecond laser-assisted procedures. Applications include cataract surgery, refractive surgery, presbyopia correction, and secondary IOL implantation. The main end users consist of hospitals, ambulatory surgical centers (ASCs), ophthalmology clinics, eye research institutes, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The intraocular lens (IOL) implants market research report is one of a series of new reports from The Business Research Company that provides intraocular lens (IOL) implants market statistics, including the intraocular lens (IOL) implants industry global market size, regional shares, competitors with the intraocular lens (IOL) implants market share, detailed intraocular lens (IOL) implants market segments, market trends, and opportunities, and any further data you may need to thrive in the intraocular lens (IOL) implants industry. These intraocular lens (IOL) implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The intraocular lens (IOL) implants market size has grown strongly in recent years. It will grow from $4.71 billion in 2024 to $5.03 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. Growth during the historic period was driven by an aging population, a rising prevalence of cataracts, increased awareness of eye health and care, greater adoption of monofocal intraocular lenses, and a surge in minimally invasive surgical procedures.

The intraocular lens (IOL) implants market size is expected to see strong growth in the next few years. It will grow to $6.51 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. Growth in the forecast period is expected to be driven by rising demand for premium intraocular lenses (IOLs), an increase in outpatient cataract procedures, wider adoption of femtosecond laser-assisted surgeries, supportive government initiatives for vision care, and improved access to eye care in emerging markets. Key trends anticipated include a shift toward toric and multifocal IOLs, continued advancements in surgical methods, the integration of artificial intelligence in ophthalmology, the development of light-adjustable lenses, and a growing preference for personalized vision correction solutions.

The increasing number of cataract surgeries is anticipated to drive the growth of the intraocular lens (IOL) implants market. Cataract surgery involves removing the eye's cloudy natural lens and replacing it with an artificial intraocular lens to restore clear vision. The rise in cataract surgeries is mainly due to the aging population, as cataracts are more common in older adults, who are more prone to vision impairment requiring surgical treatment. Intraocular lens implants improve the outcomes of cataract surgery by substituting the clouded lens with a clear artificial one, resulting in sharper vision, reduced dependence on glasses, quicker recovery, and long-lasting visual stability. For example, a report from EyeWorld Magazine, a U.S.-based ophthalmology publication, noted that in 2022, approximately 9,750 cataract surgeons in the U.S. performed 4.6 million procedures, averaging 472 surgeries each. By 2030, it is projected that around 10,000 surgeons will conduct close to 600 surgeries annually. This trend highlights the growing demand for intraocular lens implants driven by the increasing number of cataract surgeries.

Key players in the intraocular lens implants market are concentrating on developing next-generation presbyopia-correcting lenses to improve visual results and reduce patients' reliance on glasses. These advanced lenses are designed to restore clear vision at various distances-near, intermediate, and far-for individuals with presbyopia. They help minimize or eliminate the need for reading glasses or bifocals after cataract surgery, offering greater visual independence and enhancing quality of life. For instance, in June 2025, Johnson & Johnson, a U.S.-based pharmaceutical company, introduced the Tecnis Odyssey, a next-generation intraocular lens that provides clear vision across all distances and lighting conditions. This lens uses advanced optics combined with a unique diffractive surface to deliver continuous, high-contrast vision while reducing night-time visual disturbances such as halos and glare. This innovation aims to give cataract patients improved visual freedom and a better quality of life.

In January 2023, Bausch + Lomb Corporation, a U.S.-based eye health company, acquired AcuFocus Inc. for an undisclosed amount. This acquisition was intended to broaden Bausch + Lomb's intraocular lens portfolio by incorporating AcuFocus's small-aperture technology, particularly the IC-8 Apthera IOL, designed to better address the needs of cataract patients with presbyopia and mild corneal astigmatism. AcuFocus Inc. is a U.S.-based medical device firm specializing in developing innovative ophthalmic technologies, including small-aperture intraocular lenses for the treatment of presbyopia and cataracts.

Major players in the intraocular lens (iol) implants market are Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Appasamy Associates Private Limited, STAAR Surgical Company, Aurolab, Lenstec Inc., Rayner Intraocular Lenses Limited, Omni Lens Private Limited, Ophtec B.V., Hanita Lenses R.C.A Ltd., Shanghai Haohai Biological Technology Co. Ltd., Biotech Vision Care Pvt. Ltd., HumanOptics AG, Soleko S.p.A., Care Group Sight Solutions Private Limited, Cristalens Industrie SAS, SAV-IOL SA, Eyebright Medical Technology (Beijing) Co. Ltd., Eagle Optics Pvt. Ltd., SIFI S.p.A.

North America was the largest region in the intraocular lens (IOL) implants market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in intraocular lens (IOL) implants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the intraocular lens (IOL) implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The intraocular lens (IOL) implants market consists of sales of monofocal intraocular lenses, multifocal intraocular lenses, toric intraocular lenses, accommodative intraocular lenses, extended depth of focus (EDOF) intraocular lenses, and phakic intraocular lenses. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intraocular Lens (IOL) Implants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intraocular lens (iol) implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for intraocular lens (iol) implants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The intraocular lens (iol) implants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Intraocular Lens (IOL) Implants Market Characteristics

3. Intraocular Lens (IOL) Implants Market Trends And Strategies

4. Intraocular Lens (IOL) Implants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Intraocular Lens (IOL) Implants Growth Analysis And Strategic Analysis Framework

6. Intraocular Lens (IOL) Implants Market Segmentation

7. Intraocular Lens (IOL) Implants Market Regional And Country Analysis

8. Asia-Pacific Intraocular Lens (IOL) Implants Market

9. China Intraocular Lens (IOL) Implants Market

10. India Intraocular Lens (IOL) Implants Market

11. Japan Intraocular Lens (IOL) Implants Market

12. Australia Intraocular Lens (IOL) Implants Market

13. Indonesia Intraocular Lens (IOL) Implants Market

14. South Korea Intraocular Lens (IOL) Implants Market

15. Western Europe Intraocular Lens (IOL) Implants Market

16. UK Intraocular Lens (IOL) Implants Market

17. Germany Intraocular Lens (IOL) Implants Market

18. France Intraocular Lens (IOL) Implants Market

19. Italy Intraocular Lens (IOL) Implants Market

20. Spain Intraocular Lens (IOL) Implants Market

21. Eastern Europe Intraocular Lens (IOL) Implants Market

22. Russia Intraocular Lens (IOL) Implants Market

23. North America Intraocular Lens (IOL) Implants Market

24. USA Intraocular Lens (IOL) Implants Market

25. Canada Intraocular Lens (IOL) Implants Market

26. South America Intraocular Lens (IOL) Implants Market

27. Brazil Intraocular Lens (IOL) Implants Market

28. Middle East Intraocular Lens (IOL) Implants Market

29. Africa Intraocular Lens (IOL) Implants Market

30. Intraocular Lens (IOL) Implants Market Competitive Landscape And Company Profiles

31. Intraocular Lens (IOL) Implants Market Other Major And Innovative Companies

32. Global Intraocular Lens (IOL) Implants Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Intraocular Lens (IOL) Implants Market

34. Recent Developments In The Intraocular Lens (IOL) Implants Market

35. Intraocular Lens (IOL) Implants Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기